Evidence map›Paper›PMID 37755830›Full record

ArticleJAMA network open2023

Community Mobility and Depressive Symptoms During the COVID-19 Pandemic in the United States.

Roy H Perlis, Kristin Lunz Trujillo, Alauna Safarpour, Alexi Quintana, Matthew D Simonson, Jasper Perlis, Mauricio Santillana, Katherine Ognyanova, Matthew A Baum, James N Druckman and 1 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Characterizing population-level changes in human behavior during the COVID-19 pandemic in the United States.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Prevalence and correlates of irritability among U.S. adults.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Roy H PerlisMassachusetts General Hospital, Boston.
Kristin Lunz TrujilloNortheastern University, Boston, Massachusetts.
Alauna SafarpourNortheastern University, Boston, Massachusetts.
Alexi QuintanaNortheastern University, Boston, Massachusetts.
Matthew D SimonsonUniversity of Pennsylvania, Philadelphia.
Jasper PerlisMassachusetts General Hospital, Boston.
Mauricio SantillanaNortheastern University, Boston, Massachusetts.
Katherine OgnyanovaRutgers University, New Brunswick, New Jersey.
Matthew A BaumHarvard University, Cambridge, Massachusetts.
James N DruckmanNorthwestern University, Evanston, Illinois.
David LazerNortheastern University, Boston, Massachusetts.
Northeastern University · USHarvard University Press · USMassachusetts General Hospital · USNorthwestern University · USPhiladelphia University · USRutgers, The State University of New Jersey · US

Funding

Data-driven subtyping in major depressive disorderR01MH123804 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PERLIS, ROY H. · 2021 to 2024
$3.1M
Development of an Open-Source and Data-Driven Modeling Platform to Monitor and Forecast Disease ActivityR01GM130668 · NIGMS · NORTHEASTERN UNIVERSITY · PI SANTILLANA, MAURICIO · 2018 to 2022
$1.9M
Depression, Isolation, and Social Connectivity Online (DISCO)RF1MH132335 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PERLIS, ROY H. · 2022 to 2022
$1.9M
1/2 Leveraging electronic health records for pharmacogenomics of psychiatric disordersR01MH116270 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PERLIS, ROY H. · 2019 to 2022
$1.7M
NIGMS NIH HHS R01 GM130668NIMH NIH HHS R01 MH116270NIMH NIH HHS R01 MH123804NIMH NIH HHS RF1 MH132335
6 · The paper itself

Abstract

Importance: Marked elevation in levels of depressive symptoms compared with historical norms have been described during the COVID-19 pandemic, and understanding the extent to which these are associated with diminished in-person social interaction could inform public health planning for future pandemics or other disasters. Objective: To describe the association between living in a US county with diminished mobility during the COVID-19 pandemic and self-reported depressive symptoms, while accounting for potential local and state-level confounding factors. Design, Setting, and Participants: This survey study used 18 waves of a nonprobability internet survey conducted in the United States between May 2020 and April 2022. Participants included respondents who were 18 years and older and lived in 1 of the 50 US states or Washington DC. Main Outcome and Measure: Depressive symptoms measured by the Patient Health Questionnaire-9 (PHQ-9); county-level community mobility estimates from mobile apps; COVID-19 policies at the US state level from the Oxford stringency index. Results: The 192 271 survey respondents had a mean (SD) of age 43.1 (16.5) years, and 768 (0.4%) were American Indian or Alaska Native individuals, 11 448 (6.0%) were Asian individuals, 20 277 (10.5%) were Black individuals, 15 036 (7.8%) were Hispanic individuals, 1975 (1.0%) were Pacific Islander individuals, 138 702 (72.1%) were White individuals, and 4065 (2.1%) were individuals of another race. Additionally, 126 381 respondents (65.7%) identified as female and 65 890 (34.3%) as male. Mean (SD) depression severity by PHQ-9 was 7.2 (6.8). In a mixed-effects linear regression model, the mean county-level proportion of individuals not leaving home was associated with a greater level of depression symptoms (β, 2.58; 95% CI, 1.57-3.58) after adjustment for individual sociodemographic features. Results were similar after the inclusion in regression models of local COVID-19 activity, weather, and county-level economic features, and persisted after widespread availability of COVID-19 vaccination. They were attenuated by the inclusion of state-level pandemic restrictions. Two restrictions, mandatory mask-wearing in public (β, 0.23; 95% CI, 0.15-0.30) and policies cancelling public events (β, 0.37; 95% CI, 0.22-0.51), demonstrated modest independent associations with depressive symptom severity. Conclusions and Relevance: In this study, depressive symptoms were greater in locales and times with diminished community mobility. Strategies to understand the potential public health consequences of pandemic responses are needed.

Indexed as

COVID-19AdultCOVID-19 VaccinesDepressionFemaleHumansMalePandemicsSARS-CoV-2United StatesCOVID-19 Vaccines

Identifiers

PMID37755830
PMCPMC10534266
OpenAlexW4387077623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.